CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 252 filers reported holding CONMED CORP in Q2 2021. The put-call ratio across all filers is 8.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,222,431 | -17.2% | 22,037 | +11.6% | 0.01% | -11.1% |
| Q2 2023 | $2,683,963 | +5.9% | 19,751 | -19.0% | 0.01% | 0.0% |
| Q1 2023 | $2,533,249 | +2.0% | 24,391 | -12.9% | 0.01% | 0.0% |
| Q4 2022 | $2,483,072 | +22.1% | 28,013 | +10.4% | 0.01% | +12.5% |
| Q3 2022 | $2,034,000 | +5.1% | 25,375 | +25.6% | 0.01% | +14.3% |
| Q2 2022 | $1,935,000 | -26.8% | 20,202 | +13.5% | 0.01% | -12.5% |
| Q1 2022 | $2,645,000 | -5.7% | 17,806 | -10.0% | 0.01% | 0.0% |
| Q4 2021 | $2,804,000 | +3.4% | 19,778 | -4.6% | 0.01% | 0.0% |
| Q3 2021 | $2,711,000 | +10.4% | 20,723 | +16.0% | 0.01% | 0.0% |
| Q2 2021 | $2,455,000 | -6.9% | 17,865 | -11.6% | 0.01% | -11.1% |
| Q1 2021 | $2,638,000 | -10.9% | 20,201 | -23.6% | 0.01% | -10.0% |
| Q4 2020 | $2,961,000 | +45.1% | 26,437 | +1.9% | 0.01% | +25.0% |
| Q3 2020 | $2,040,000 | +3.4% | 25,934 | -5.3% | 0.01% | 0.0% |
| Q2 2020 | $1,972,000 | – | 27,395 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 1,385,000 | $58,862,000 | 5.19% |
| SIGNIA CAPITAL MANAGEMENT LLC | 146,589 | $6,230,000 | 2.32% |
| HEARTLAND ADVISORS INC | 1,773,782 | $75,386,000 | 1.31% |
| NORTH TIDE CAPITAL, LLC | 350,000 | $14,875,000 | 1.30% |
| Aurora Investment Counsel | 38,196 | $1,623,000 | 1.07% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 571,150 | $24,274,000 | 0.99% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 102,500 | $4,356,000 | 0.90% |
| Tributary Capital Management, LLC | 98,862 | $4,202,000 | 0.83% |
| PERKINS CAPITAL MANAGEMENT INC | 27,850 | $1,184,000 | 0.80% |
| Iguana Healthcare Management, LLC | 25,000 | $1,063,000 | 0.61% |